Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK
Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK
Recruiting · NCT06666348 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK | Pediatric Low-grade Glioma | Recruiting | Phase 1 / Phase 2 | 2026-08-11 | NCT06666348 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| St. Justine's Hospital | 39 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alberta Children's Hospital | Calgary | Canada | 70 |
| Cancer Care Manitoba | Winnipeg | Canada | 10 |
| Children's Hospital, London Health Sciences Centre | London | Canada | 1 |
| Childrens and Womens Health Centre of British Columbia - British Columbia Childrens Hospital | Vancouver | Canada | 1 |
| CHU de Québec - Université Laval | Québec | Canada | 4 |
| CHU de Sherbrooke | Sherbrooke | Canada | 1 |
| CHU Sainte-Justine | Montreal | Canada | 36 |
| Stollery Children's Hospital | Edmonton | Canada | 1 |
| The Hospital for Sick Children | Toronto | Canada | 20 |